It was investigated that the levels of oxidative markers, including glutathione peroxidase and SOD, in the mitochondrial and synaptosome fractions in the human postmortem frontal cortex decreased and correlated with cognitive impairment in AD patients. This evidence concerns the gene SOD1 and Alzheimer disease.